Create Alert
Watchlist

Ind-Swift Ltd. - (Amalgamated)

₹15.70
0.00 (0.00%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
14.86
Prev. Close
15.70
Volume
0
Total traded value
NA
Upper Circuit
18.84
Lower Circuit
12.56

Fundamentals

Market Cap₹85Cr
ROE-1.94%
P/E Ratio(TTM)0.30
EPS(TTM)52.33
P/B Ratio0.00
Dividend Yield0.00%
Industry P/E33.28
Book Value-74.28
Debt to Equity-2.17
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ind Swift

Ind-Swift, established in 1986, is a research-focused pharmaceutical company known for its world-class finished dosage forms, which are ready-to-consume medicines. The group's vision is to act as a stakeholder in serving humanity, providing high-quality pharmaceuticals that alleviate suffering and help build a healthier world. It remains committed to its mission of delivering innovative healthcare solutions to its customers all over the globe, aiming for excellence in healthcare. The core business of the company is the manufacturing of a wide range of pharmaceutical products for both local and international markets. In the Indian domestic market, the company was a pioneer in the generic medicine business and continues to maintain a strong market position today. Globally, Ind-Swift has secured over 400 Marketing Authorizations and has more than 300 product dossiers under registration across several continents.;
Parent OrganisationInd Swift
Managing DirectorDr. Gopal Munjal
Founded1986
BSE Symbol524652

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
55.58%
Retail And Others
44.42%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
59.43
Ajanta Pharma
NA
(0.00%)
33.35
Gland Pharma
NA
(0.00%)
34.69
Eris Lifesciences
NA
(0.00%)
47.27
2025

14
Aug
Merger into Ind-Swift Laboratories Ltd
Ex date

Merger into Ind-Swift Laboratories Ltd. For every 100 shares you have in the original company, you will receive 15 shares in the new combined company after merger.
Ratio100:15
Ex date14 Aug ‘25
Record date14 Aug ‘25
Announcement date6 Sep ‘23
25
Jun
Annual Result
Release date
30
May
Annual Result
Release date
11
Feb
Quarterly Result
Release date
2024
14
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date
14
May
Annual Result
Release date
Events calendar
View upcoming events in other stocks